Seizure News and Research

Latest Seizure News and Research

Brains are hardwired to act according to the Golden Rule

Wesley Autrey, a black construction worker, a Navy veteran and 55-year-old father of two, didn't know the young man standing beside him.

24 Mar 2008

Experts warn, no Easter chocolate for pets!

Experts are warning pet owners not to give their dogs or cats chocolate over the Easter period.

19 Mar 2008

Only two per cent of 700 paediatric drug trials included independent safety checks

Only two per cent of paediatric drug trials reported that they had established independent safety monitoring committees that can help lead to the early detection of adverse drug reactions, according to a major review in the April issue of Acta Paediatrica.

19 Mar 2008

Severe West Nile infection could lead to lifetime of symptoms

Most people who suffer severe infection with West Nile virus still experience symptoms years after infection and many may continue to experience these symptoms for the rest of their lives according to research presented (March 17) at the 2008 International Conference on Emerging Infectious Diseases in Atlanta, Georgia.

18 Mar 2008

Good news for people with glycogen storage disease type Ia

A gene therapy treatment that restores a missing liver enzyme in test animals could provide a cure for a rare metabolic disorder in humans, according to Duke University Medical Center researchers.

13 Mar 2008

Structure reveals how cells 'sugar-coat' proteins - process essential to many proteins' functions can lead to disease when gone awry

Biologists at the U.S. Department of Energy's Brookhaven National Laboratory, Stony Brook University, and the University of Wurzburg, Germany, have deciphered the structure of a large protein complex responsible for adding sugar molecules to newly formed proteins - a process essential to many proteins' functions.

11 Mar 2008

AstraZeneca submits sNDA for SEROQUEL XR for treatment of major depressive disorder

AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of major depressive disorder (MDD) as monotherapy, adjunct therapy, and maintenance therapy in adult patients.

1 Mar 2008

Researchers explain why Avastin can cause potentially fatal brain inflammation

New research by scientists at Schepens Eye Research Institute may help explain why the anti-cancer drug Avastin, which targets a growth factor responsible for creation of new blood vessels, causes potentially fatal brain inflammation in certain patients.

14 Feb 2008

Fake antimalarial drugs analysis highlights threat to global health

A unique collaboration between scientists, public health workers and police has led to the arrest by the Chinese authorities of alleged traders of fake anti-malarial drugs in southern China and the seizure of a large quantity of drugs.

13 Feb 2008

Avastin (bevacizumab) damages brain vessels

The cancer drug Avastin (bevacizumab) is used to treat advanced bowel cancer in combination with chemotherapy.

12 Feb 2008

Poison prevention and treatment

Each year, approximately 2.4 million people - more than half under age 6 - swallow or have contact with a poisonous substance..

11 Feb 2008

Cell transplant treatment for diabetics gets the green light in the UK

Sufferers in the UK with Type 1 diabetes have been given new hope of a cure with a nationwide cell transplant programme.

11 Feb 2008

FDA to stop the marketing of unapproved injectable colchicine

The U.S. Food and Drug Administration has announced its intention to take enforcement action against companies marketing unapproved injectable colchicine, a drug used to treat gout.

7 Feb 2008

Chemical chaperone could open door to treatment of neurological disorder

An unexpected finding turned out to be a clue leading researchers at Washington University School of Medicine in St. Louis to propose a new treatment approach for Niemann-Pick disease, a rare, deadly neurodegenerative disorder.

7 Feb 2008

Enbrel shown to significantly reduced levels of C-reactive protein

Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. Median reduction in CRP levels was 10 times greater in the ENBREL treated group compared to the placebo treated group.

5 Feb 2008

Deafness and seizures result when glutamate protein deleted in mice

Scientists have discovered that mice genetically engineered to lack a particular protein in the brain have profound deafness and seizures.

25 Jan 2008

Auditory neurons in humans far more sensitive to fine sound frequencies than most mammals

The human ear is exquisitely tuned to discern different sound frequencies, whether such tones are high or low, near or far.

11 Jan 2008

Bio-identical hormone replacement therapies targeted by FDA

The U.S. Food and Drug Administration (FDA) sent letters warning seven pharmacy operations that the claims they make about the safety and effectiveness of their so-called "bio-identical hormone replacement therapy," or "BHRT" products are unsupported by medical evidence, and are considered false and misleading by the agency.

10 Jan 2008

Discovery of a core mechanism underlying Fragile X syndrome

Researchers at UT Southwestern Medical Center are uncovering how brain cells are affected in Fragile X syndrome, the most common cause of inherited mental retardation and the most common genetic cause of autism.

9 Jan 2008

New gene identified for cerebral venous thrombosis

Researchers have identified a new gene linked to cerebral venous thrombosis, a condition that causes blood clots in the veins of the brain that can lead to stroke.

8 Jan 2008